Literature DB >> 7487072

Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.

L Jin1, D L Peterson.   

Abstract

The genome of the hepatitis C virus directs the synthesis of a single polyprotein, which is proteolytically cleaved into at least nine functional proteins. The amino-terminal portion of the polyprotein forms the structural proteins, while the carboxy-terminal region constitutes a variety of viral enzymes. The nonstructural 3 (NS3) protein, consisting of amino acids 1027-1657 of the polyprotein, is believed to be a multifunctional protein with an amino-terminal serine protease domain, which is involved in polyprotein processing, and a carboxy-terminal ATPase/RNA helicase domain, presumably involved in viral replication. We have assembled an expression vector which directs the synthesis of residues 1207-1612 of the polyprotein with an amino-terminal polyhistidine purification tag. This portion of the NS3 protein contains the putative ATPase/helicase domain. The protein has been purified to yield 30-50 mg of enzymatically active protein per liter of culture. The purified NS3 protein has both NTPase and RNA helicase activities. ATP is the preferred substrate for the NTPase; GTP is also utilized; however, UTP is a very poor substrate and CTP is not utilized. The RNA helicase activity is dependent on ATP and divalent cation. Either manganese or magnesium can serve as the divalent cation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487072     DOI: 10.1006/abbi.1995.0008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  37 in total

1.  The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.

Authors:  David N Frick; Ryan S Rypma; Angela M I Lam; Baohua Gu
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

Review 2.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates.

Authors:  N Stäuber; J Martinez-Costas; G Sutton; K Monastyrskaya; P Roy
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  The motif V of plum pox potyvirus CI RNA helicase is involved in NTP hydrolysis and is essential for virus RNA replication.

Authors:  A Fernández; H S Guo; P Sáenz; L Simón-Buela; M Gómez de Cedrón; J A García
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

5.  ATPase, GTPase, and RNA binding activities associated with the 206-kilodalton protein of turnip yellow mosaic virus.

Authors:  G Kadaré; C David; A L Haenni
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein.

Authors:  G M Heilek; M G Peterson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 7.  Virus-encoded RNA helicases.

Authors:  G Kadaré; A L Haenni
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization.

Authors:  S Muramatsu; S Ishido; T Fujita; M Itoh; H Hotta
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Characterization of RNA-dependent RNA polymerase activity of CSFV NS5B proteins expressed in Escherichia coli.

Authors:  Ming Xiao; Yujing Wang; Jiakuan Chen; Bo Li
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

10.  Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses.

Authors:  G Filocamo; L Pacini; C Nardi; L Bartholomew; M Scaturro; P Delmastro; A Tramontano; R De Francesco; G Migliaccio
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.